Surface Functionalized RBC Membrane-Derived Nanoparticles for Targeted Drug Delivery to Attenuate Fatty Liver Disease
Alap Ali Zahid, Jiaqi Huang, Nica M. Borradaile, Arghya Paul
This study develops hepatocyte-targeting cell membrane-derived nanoparticles loaded with resmetirom to treat MASLD, showing improved bioactivity in vitro.
bioRxiv · Feb 25, 2026 · PreprintBioengineering